As of 2025-07-15, the Fair Value of HLS Therapeutics Inc (HLS.TO) is -3.89 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.86 CAD, the upside of HLS Therapeutics Inc is -180.09%.
With the market price of 4.86 CAD and our fair value calculation, HLS Therapeutics Inc (HLS.TO) is not a good investment. Investing in HLS.TO stocks now will result in a potential loss of 180.09%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -15.30 | -13.10 | -23.60 | -27.53 | -19.66 | -19.84 |
| YoY growth | 21.94% | 14.38% | -80.15% | -16.66% | 28.61% | -6.38% |
| Market Cap (mil) | 153.72 |
| P/E | |
| Forward P/E |
| EPS | -0.57 |
| Avg earnings growth rate | -6.38% |
| TTM earnings | -17.98 |